• レポートコード:MRC2204B005 • 出版社/出版日:Transparency Market Research / 2022年4月20日 • レポート形態:英文、PDF、177ページ • 納品方法:Eメール • 産業分類:消費財 |
Single User | ¥857,660 (USD5,795) | ▷ お問い合わせ |
Multi User | ¥1,301,660 (USD8,795) | ▷ お問い合わせ |
Corporate License | ¥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Transparency Market Research社の本市場調査資料では、世界の医師調剤薬用化粧品市場を広く調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、製品種類別(フェイスケア、スキンケア)分析、疾患別分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)分析、競争状況など、以下の構成でまとめました。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・キーインサイト ・世界の医師調剤薬用化粧品市場規模:製品種類別(フェイスケア、スキンケア) ・世界の医師調剤薬用化粧品市場規模:疾患別 ・世界の医師調剤薬用化粧品市場規模:地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ) ・競争状況 |
TMR’s report on the global physician dispensed cosmeceuticals market studies the past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides revenue of the global physician dispensed cosmeceuticals market for the period 2017–2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global physician dispensed cosmeceuticals market during the forecast period.
The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global physician dispensed cosmeceuticals market.
Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global physician dispensed cosmeceuticals market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global physician dispensed cosmeceuticals market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global physician dispensed cosmeceuticals market.
The report delves into the competitive landscape of the global physician dispensed cosmeceuticals market. Key players operating in the global physician dispensed cosmeceuticals market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global physician dispensed cosmeceuticals market that have been profiled in this report.
Key Questions Answered in Physician Dispensed Cosmeceuticals Market Report
What is the scope of growth of product companies in the global physician dispensed cosmeceuticals market?
What will be the Y-o-Y growth of the global physician dispensed cosmeceuticals market between 2019 and 2031?
What is the influence of changing trends in technologies on the global physician dispensed cosmeceuticals market?
Will North America continue to be the most profitable market for physician dispensed cosmeceuticals providers?
Which factors are anticipated to hamper the growth of the global physician dispensed cosmeceuticals market during the forecast period?
Which are the leading companies in the global physician dispensed cosmeceuticals market?
Research Methodology
A unique research methodology has been utilized by TMR to conduct comprehensive research on the growth of the global physician dispensed cosmeceuticals market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.
Secondary methods referred to by analysts during the production of the global physician dispensed cosmeceuticals market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the physician dispensed cosmeceuticals market as primary methods.
These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the physician dispensed cosmeceuticals market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global physician dispensed cosmeceuticals market with accuracy. The study also uses the top-down approach to assess the revenues for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global physician dispensed cosmeceuticals market more reliably and accurately.
Physician Dispensed Cosmeceuticals Market – Segmentation
*** Product Type
Face-care
Skincare
*** Application
Skin Lightening or De-pigmenting
Rhytide Reduction
Anti-wrinkle / Aging
Scar-reducing
Others
*** Region
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Physician Dispensed Cosmeceuticals Market
4. Market Overview
4.1. Introduction
4.1.1. Product Type Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Physician Dispensed Cosmeceuticals Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Product/ Brand Analysis
5.2. Key Mergers & Acquisitions
5.3. Regulatory Scenario by Region/globally
5.4. COVID-19 Pandemics Impact on Industry (value chain and short / mid / long term impact)
6. Global Physician Dispensed Cosmeceuticals Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Face-care
6.3.2. Skincare
6.4. Market Attractiveness Analysis, by Product Type
7. Global Physician Dispensed Cosmeceuticals Market Analysis and Forecast, by Indication
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Indication, 2017–2031
7.3.1. Skin Lightening or De-pigmenting
7.3.2. Rhytide Reduction
7.3.3. Anti-wrinkle/Aging
7.3.4. Scar-reducing
7.3.5. Others
7.4. Market Attractiveness Analysis, by Indication
8. Global Physician Dispensed Cosmeceuticals Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Physician Dispensed Cosmeceuticals Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Product Type, 2017–2031
9.2.1. Face-care
9.2.2. Skincare
9.3. Market Value Forecast, by Indication, 2017–2031
9.3.1. Skin Lightening or De-pigmenting
9.3.2. Rhytide Reduction
9.3.3. Anti-wrinkle/Aging
9.3.4. Scar-reducing
9.3.5. Others
9.4. Market Value Forecast, by Country, 2017–2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Product Type
9.5.2. By Indication
9.5.3. By Country
10. Europe Physician Dispensed Cosmeceuticals Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2017–2031
10.2.1. Face-care
10.2.2. Skincare
10.3. Market Value Forecast, by Indication, 2017–2031
10.3.1. Skin Lightening or De-pigmenting
10.3.2. Rhytide Reduction
10.3.3. Anti-wrinkle/Aging
10.3.4. Scar-reducing
10.3.5. Others
10.4. Market Value Forecast, by Country/Sub-region, 2017–2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Product Type
10.5.2. By Indication
10.5.3. By Country/Sub-region
11. Asia Pacific Physician Dispensed Cosmeceuticals Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017–2031
11.2.1. Face-care
11.2.2. Skincare
11.3. Market Value Forecast, by Indication, 2017–2031
11.3.1. Skin Lightening or De-pigmenting
11.3.2. Rhytide Reduction
11.3.3. Anti-wrinkle/Aging
11.3.4. Scar-reducing
11.3.5. Others
11.4. Market Value Forecast, by Country/Sub-region, 2017–2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Product Type
11.5.2. By Indication
11.5.3. By Country/Sub-region
12. Latin America Physician Dispensed Cosmeceuticals Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017–2031
12.2.1. Face-care
12.2.2. Skincare
12.3. Market Value Forecast, by Indication, 2017–2031
12.3.1. Skin Lightening or De-pigmenting
12.3.2. Rhytide Reduction
12.3.3. Anti-wrinkle/Aging
12.3.4. Scar-reducing
12.3.5. Others
12.4. Market Value Forecast, by Country/Sub-region, 2017–2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Product Type
12.5.2. By Indication
12.5.3. By Country/Sub-region
13. Middle East & Africa Physician Dispensed Cosmeceuticals Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017–2031
13.2.1. Face-care
13.2.2. Skincare
13.3. Market Value Forecast, by Indication, 2017–2031
13.3.1. Skin Lightening or De-pigmenting
13.3.2. Rhytide Reduction
13.3.3. Anti-wrinkle/Aging
13.3.4. Scar-reducing
13.3.5. Others
13.4. Market Value Forecast, by Country/Sub-region, 2017–2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Product Type
13.5.2. By Indication
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (by tier and size of companies)
14.2. Company Profiles
14.2.1. AbbVie Inc. (Allergan)
14.2.1.1. Company Overview
14.2.1.2. Financial Overview
14.2.1.3. Product Portfolio
14.2.1.4. SWOT Analysis
14.2.1.5. Strategic Overview
14.2.2. L’Oreal S.A.
14.2.2.1. Company Overview
14.2.2.2. Financial Overview
14.2.2.3. Product Portfolio
14.2.2.4. SWOT Analysis
14.2.2.5. Strategic Overview
14.2.3. Jan Marini Skin Research, Inc.
14.2.3.1. Company Overview
14.2.3.2. Financial Overview
14.2.3.3. Product Portfolio
14.2.3.4. SWOT Analysis
14.2.3.5. Strategic Overview
14.2.4. Athena Cosmetics, Inc.
14.2.4.1. Company Overview
14.2.4.2. Financial Overview
14.2.4.3. Product Portfolio
14.2.4.4. SWOT Analysis
14.2.4.5. Strategic Overview
14.2.5. ZO Skin Health Inc.
14.2.5.1. Company Overview
14.2.5.2. Financial Overview
14.2.5.3. Product Portfolio
14.2.5.4. SWOT Analysis
14.2.5.5. Strategic Overview
14.2.6. Galderma Laboratories, L.P.
14.2.6.1. Company Overview
14.2.6.2. Financial Overview
14.2.6.3. Product Portfolio
14.2.6.4. SWOT Analysis
14.2.6.5. Strategic Overview
14.2.7. Procter & Gamble Co.
14.2.7.1. Company Overview
14.2.7.2. Financial Overview
14.2.7.3. Product Portfolio
14.2.7.4. SWOT Analysis
14.2.7.5. Strategic Overview
14.2.8. The Estée Lauder Companies, Inc.
14.2.8.1. Company Overview
14.2.8.2. Financial Overview
14.2.8.3. Product Portfolio
14.2.8.4. SWOT Analysis
14.2.8.5. Strategic Overview
14.2.9. Merz Pharma
14.2.9.1. Company Overview
14.2.9.2. Financial Overview
14.2.9.3. Product Portfolio
14.2.9.4. SWOT Analysis
14.2.9.5. Strategic Overview
14.2.10. Obagi Cosmeceuticals LLC
14.2.10.1. Company Overview
14.2.10.2. Financial Overview
14.2.10.3. Product Portfolio
14.2.10.4. SWOT Analysis
14.2.10.5. Strategic Overview
14.2.11. iS CLINICAL
14.2.11.1. Company Overview
14.2.11.2. Financial Overview
14.2.11.3. Product Portfolio
14.2.11.4. SWOT Analysis
14.2.11.5. Strategic Overview
14.2.12. Neutrogena
14.2.12.1. Company Overview
14.2.12.2. Financial Overview
14.2.12.3. Product Portfolio
14.2.12.4. SWOT Analysis
14.2.12.5. Strategic Overview
List of TablesTable 01: Global Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Product Type 2017–2031
Table 02: Global Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Indication, 2017‒2031
Table 03: Global Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 04: North America Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031
Table 05: North America Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 06: North America Physician Dispensed Cosmeceuticals Market (US$ Mn) Forecast, by Indication, 2017–2031
Table 07: Europe Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031
Table 08: Europe Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 09: Europe Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 10: Asia Pacific Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031
Table 11: Asia Pacific Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 12: Asia Pacific Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 13: Latin America Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031
Table 14: Latin America Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 15: Asia Pacific Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 16: Middle East & Africa Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031
Table 17: Middle East & Africa Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 18: Middle East & Africa Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Indication, 2017–2031
List of Figures
Figure 01: Global Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Global Physician Dispensed Cosmeceuticals Market Value Share, by Product Type, 2020
Figure 03: Global Physician Dispensed Cosmeceuticals Market Value Share, by Indication, 2020
Figure 04: Global Physician Dispensed Cosmeceuticals Market Value Share, by Region, 2020
Figure 05: Global Physician Dispensed Cosmeceuticals Market, by Product Type, 2020 and 2031
Figure 06: Global Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 07: Global Physician Dispensed Cosmeceuticals Market (US$ Mn), by Face-care, 2017–2031
Figure 08: Global Physician Dispensed Cosmeceuticals Market (US$ Mn), by Skincare, 2017–2031
Figure 09: Global Physician Dispensed Cosmeceuticals Market, by Indication, 2020 and 2031
Figure 10: Global Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Indication, 2021–2031
Figure 11: Global Physician Dispensed Cosmeceuticals Market (US$ Mn), by Skin Lightening or De-pigmenting, 2017–2031
Figure 12: Global Physician Dispensed Cosmeceuticals Market (US$ Mn), by Rhytide Reduction, 2017–2031
Figure 13: Global Physician Dispensed Cosmeceuticals Market (US$ Mn), by Anti-wrinkle/Aging, 2017–2031
Figure 14: Global Physician Dispensed Cosmeceuticals Market (US$ Mn), by Scar-reducing, 2017–2031
Figure 15: Global Physician Dispensed Cosmeceuticals Market (US$ Mn), by Others, 2017–2031
Figure 16: Global Physician Dispensed Cosmeceuticals Market Value Share Analysis, by Region, 2020 and 2031
Figure 17: Global Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Region, 2021–2031
Figure 18: North America Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, 2017–2031
Figure 19: North America Physician Dispensed Cosmeceuticals Market Value Share Analysis, by Country, 2020 and 2031
Figure 20: North America Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Country, 2021–2031
Figure 21: North America Physician Dispensed Cosmeceuticals Market, by Product Type, 2020 and 2031
Figure 22: North America Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 23: North America Physician Dispensed Cosmeceuticals Market, by Indication, 2020 and 2031
Figure 24: North America Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Indication, 2021–2031
Figure 25: Europe Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, 2017–2031
Figure 26: Europe Physician Dispensed Cosmeceuticals Market Value Share Analysis, by Country/Sub-Region, 2020 and 2031
Figure 27: Europe Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 28: Europe Physician Dispensed Cosmeceuticals Market, by Product Type, 2020 and 2031
Figure 29: Europe Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 30: Europe Physician Dispensed Cosmeceuticals Market, by Indication, 2020 and 2031
Figure 31: Europe Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Indication, 2021–2031
Figure 32: Asia Pacific Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, 2017–2031
Figure 33: Asia Pacific Physician Dispensed Cosmeceuticals Market Value Share Analysis, by Country/Sub-Region, 2020 and 2031
Figure 34: Asia Pacific Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 35: Asia Pacific Physician Dispensed Cosmeceuticals Market, by Indication, 2020 and 2031
Figure 36: Asia Pacific Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Indication, 2021–2031
Figure 37: Latin America Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, 2017–2031
Figure 38: Latin America Physician Dispensed Cosmeceuticals Market Value Share Analysis, by Country/Sub-Region, 2020 and 2031
Figure 39: Latin America Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 40: Latin America Physician Dispensed Cosmeceuticals Market, by Product Type, 2020 and 2031
Figure 41: Latin America Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 42: Latin America Physician Dispensed Cosmeceuticals Market, by Indication, 2020 and 2031
Figure 43: Latin America Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Indication, 2021–2031
Figure 44: Middle East & Africa Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, 2017–2031
Figure 45: Middle East & Africa Physician Dispensed Cosmeceuticals Market Value Share Analysis, by Country/Sub-Region, 2020 and 2031
Figure 46: Middle East & Africa Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 47: Middle East & Africa Physician Dispensed Cosmeceuticals Market, by Product Type, 2020 and 2031
Figure 48: Middle East & Africa Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 49: Middle East & Africa Physician Dispensed Cosmeceuticals Market, by Indication, 2020 and 2031
Figure 50: Middle East & Africa Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Indication, 2021–2031